*** Need an answer to your GCP query ? Post your query at HelpDesk ***
Follow us on
Process validation

Establishing by objective evidence that a process consistently produces a result or product meeting its predetermined specifications.
 Forums
Board Index Latest Posts Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 12:12:20
Managing Clinical Trials   by  on 2010-07-15 16:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 10:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 10:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 09:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 09:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 11:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 11:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 01:40:32
 Subject :Newer Non-Statin Drugs for Reducing Cholesterol.. 2010-04-13 07:57:20 
GCP HelpDesk
Moderator
Joined: 2009-06-18 15:31:58
Posts: 62
Location: 
Dear Friends, 
 
Please find attached a review article which gives the newer nonstatin drugs for reducing cholesterol. 
 
The newer agents are  
 
Lapaquistat:squalene synthase inhibitor
Implitapide:Microsomal triglyceride transport protein inhibitor
Mipomersen: ApoB100 Antisense oligonucelotide 
 
Kind regards,


Attachments
 Newer drugs to reduce cholesterol.pdf [314 KB] ::
IP Logged
GCP HelpDesk
Page # 


Powered by ccBoard